This HTML5 document contains 127 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n12http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n9https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33209343
rdf:type
wikibase:Item
schema:description
2004年论文 научни чланак 2004年論文 2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած 2004年论文 научна статия bilimsel makale scientific article vitskapeleg artikkel artykuł naukowy naučni članak tudományos cikk artigo científico 2004 nî lūn-bûn επιστημονικό άρθρο سائنسی مضمون wissenschaftlicher Artikel articolo scientifico article científic artikull shkencor teaduslik artikkel บทความทางวิทยาศาสตร์ 2004 թվականի հուլիսին հրատարակված գիտական հոդված tieteellinen artikkeli مقالة علمية 2004년 논문 scienca artikolo 2004年論文 artículu científicu espublizáu en 2004 article scientific мақолаи илмӣ mokslinis straipsnis научная статья videnskabelig artikel (udgivet 2004) 2004年论文 vědecký článek 2004年の論文 artículo científico publicado en 2004 სამეცნიერო სტატია artigo científico (publicado na 2004) 2004年论文 wetenschappelijk artikel 2004年論文 artikulong pang-agham научни чланак мақолаи илмӣ 2004年论文 2004年論文 articol științific artigo científico (publicado na 2004) vetenskaplig artikel 2004年論文 vedecký článok vitenskapelig artikkel 2004年论文 ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ article scientifique (publié 2004) bài báo khoa học مقالهٔ علمی наукова стаття, опублікована в липні 2004 מאמר מדעי
p:P577
wds:Q33209343-4A6C3564-93B0-459F-97BF-4F3794BB2669
wdt:P577
2004-07-28T00:00:00Z
p:P2888
wds:Q33209343-C791CFD5-1604-428A-ACAD-67C684552C46
wdt:P2888
n9:s00280-004-0854-6
p:P2093
wds:Q33209343-3A731CFB-B580-4F8F-8509-02E852E40E89 wds:Q33209343-5077B58A-9AD2-4088-A8F9-FC37FF4A7505 wds:Q33209343-3F717ACF-C7F0-4A28-8625-FEF875CABF0F wds:Q33209343-3FD93EB0-22FA-49C6-8756-1B71CB41A1B5 wds:Q33209343-606D906A-20DE-4825-883D-248722FB43F2 wds:Q33209343-5DE2DFAA-863D-4C5C-BB77-EF602D9CBCB2 wds:Q33209343-8C413F2B-3B04-4BCA-8CD2-BDE32EF6937D wds:Q33209343-796414DE-EC7F-42B8-85E1-A004A0DC584C wds:Q33209343-7F200069-8B42-4741-8834-38A3AD98B838 wds:Q33209343-C0306B74-6B18-4112-B0A5-FC159F1B1746 wds:Q33209343-91007FC9-73E3-4A1C-9C49-0C85A0AA547E wds:Q33209343-CC16F92B-86D7-47C2-8335-73B82FBF7885 wds:Q33209343-E986DC4A-91A9-4EA2-832B-295A8D393871
wdt:P2093
Jewell RC Luyten GP Wissel PS Purvis NB Jr Paul EM Planting AS van der Burg ME Sparreboom A de Leeuw K Verweij J van der Gaast A de Boer-Dennert M Sonneveld P
rdfs:label
A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors
skos:prefLabel
A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors
schema:name
A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors
p:P1476
wds:Q33209343-CD8FF6D1-134C-44EB-ACD8-83A1CB12B19A
wdt:P1476
A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors
p:P304
wds:Q33209343-D63744FB-309D-4B87-ACE0-B035F8299CE3
wdt:P304
91-99
p:P31
wds:Q33209343-B2942EF3-D541-443B-9B2D-10944B8FA285
wdt:P31
wd:Q13442814
p:P921
wds:Q33209343-6FFBCE56-0094-4F89-8130-2011B02434A1 wds:Q33209343-FFBC73D6-B0E7-4E8D-9DED-3A69ECE8A8BA
wdt:P921
wd:Q128406 wd:Q18936
p:P698
wds:Q33209343-8ACE44BB-6F1D-4F13-96F9-7794185C2748
wdtn:P698
n11:15565444
wdt:P698
15565444
p:P1433
wds:Q33209343-DE11256A-F542-43A1-BE67-5A526D3C83A5
wdt:P1433
wd:Q326137
p:P433
wds:Q33209343-CBC71693-9E20-4BA3-BEDF-C000D8EF3208
p:P478
wds:Q33209343-02AECDDE-F1AE-40AA-A0BC-025761592903
wdt:P433
1
wdt:P478
55
p:P356
wds:Q33209343-5E64410D-E421-470E-BF3E-7E789BCC34DB
wdtn:P356
n12:S00280-004-0854-6
wdt:P356
10.1007/S00280-004-0854-6
p:P5875
wds:Q33209343-07C0242D-72FC-4A57-8A20-D45A213B22A6
wdt:P5875
8162846
p:P6179
wds:Q33209343-FDC1A33F-5666-415F-A4C9-7CECD84600E9
wdt:P6179
1044964091